Go offline with the Player FM app!
Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer
Manage episode 333078086 series 3264057
In this episode, Sandip Patel, MD shares his thoughts on optimizing immune checkpoint inhibitor (ICI) therapy in advanced non-small-cell lung cancer (NSCLC) and discusses best practices for individualizing therapy decisions and managing adverse events.
Topics include:
- Currently approved ICIs
- Role of biomarker and PD-L1 testing in advanced NSCLC
- Strategies to individualize ICI treatment for patients with advanced NSCLC
- Strategies for identifying and managing immune-related adverse events in patients treated with ICI
Presenter:
Sandip P. Patel, MD
Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California – San Diego
La Jolla, California
Link to full program:
https://bit.ly/39vuCHC
90 episodes
Manage episode 333078086 series 3264057
In this episode, Sandip Patel, MD shares his thoughts on optimizing immune checkpoint inhibitor (ICI) therapy in advanced non-small-cell lung cancer (NSCLC) and discusses best practices for individualizing therapy decisions and managing adverse events.
Topics include:
- Currently approved ICIs
- Role of biomarker and PD-L1 testing in advanced NSCLC
- Strategies to individualize ICI treatment for patients with advanced NSCLC
- Strategies for identifying and managing immune-related adverse events in patients treated with ICI
Presenter:
Sandip P. Patel, MD
Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California – San Diego
La Jolla, California
Link to full program:
https://bit.ly/39vuCHC
90 episodes
Minden epizód
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.